This article is more than 5 years old. Information may no longer be current.

SynergEyes receives FDA approval for hybrid lens technology

Add topic to email alerts

Receive an email when new articles are posted on

Please provide your email address to receive an email when new articles are posted on .

Subscribe

Added to email alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

CARLSBAD, Calif. — The U.S. Food and Drug Administration has approved SynergEyes' next-generation silicone hydrogel hybrid contact lenses for correcting hyperopic, myopic and astigmatic refractive error, including presbyopia, in aphakic and non-aphakic eyes, the company announced in a press release.

SynergEyes plans to market the new hybrid technology as two separate contact lenses: the Duette hybrid contact lens for astigmatism, which is currently available in limited release, and the Duette multifocal lens for presbyopia, the release said.

Both lenses, which feature SynergEyes' MaxVu rigid gas permeable material, as well as its Flex2O silicone hydrogel skirt, are indicated for daily wear to correct up to ±20 D in eyes with up to +6 D of astigmatism, according to the release.

"Duette hybrid contact lenses represent a significant advancement in the contact lens industry and give eye care professionals an innovative product that delivers an unprecedented combination of visual acuity and comfort to a broad range of patients," Jim Ham, CEO of SynergEyes, said in the release.

A nationwide launch of the hybrid contact lenses for astigmatism and a limited release of the multifocal lenses are planned for early 2011.